Early age peanut oral immunotherapy is safe and effective at achieving desensitization in 27 pediatric patients with peanut allergy.
IF 4.3
2区 医学
Q2 ALLERGY
引用次数: 0
早期花生口服免疫疗法对 27 名花生过敏的儿科患者来说是安全有效的脱敏疗法。
本文章由计算机程序翻译，如有差异，请以英文原文为准。
求助全文
约1分钟内获得全文
求助全文
来源期刊
CiteScore
9.10
自引率
9.10%
发文量
200
审稿时长
4-8 weeks
期刊介绍：
Pediatric Allergy and Immunology is the world''s leading journal in pediatric allergy, publishing original contributions and comprehensive reviews related to the understanding and treatment of immune deficiency and allergic inflammatory and infectious diseases in children.
Other areas of interest include: development of specific and accessory immunity; the immunological interaction during pregnancy and lactation between mother and child.
As Pediatric Allergy and Immunology promotes communication between scientists engaged in basic research and clinicians working with children, we publish both clinical and experimental work.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
